2025-12-22 - Analysis Report
Okay, here's a comprehensive analysis of Tempus AI Inc. (TEM) based on the provided data, broken down into simple numbers first, followed by analysis.

**0) Report Type:** English Analysis of Tempus AI (TEM)

**1) Return Rate Comparison:**

*   **TEM Cumulative Return:** 15.06%
*   **VOO (S&P 500) Cumulative Return:** 30.11%
*   **Divergence:** -15.0 (TEM underperformed VOO by 15.0%)
*   **Relative Divergence:** 22.3 (TEM's divergence is in the lower 22.3% of its historical divergence range).

**Company Overview:** Tempus AI Inc is a company focused on precision medicine through data and artificial intelligence.

**Alpha, Beta Analysis Table:**

|            | CAGR  | MDD   | Alpha   | Beta | Cap(B) |
| ---------- | ----- | ----- | ------- | ---- | ------ |
| 2023-2025  | 15.0% | 76.7% | -14.0%  | 0.3  | 11.5   |

*   **CAGR:** 15.0% (Compound Annual Growth Rate from 2023-2025)
*   **MDD:** 76.7% (Maximum Drawdown - potential peak-to-trough decline)
*   **Alpha:** -14.0% (Underperformance relative to a benchmark)
*   **Beta:** 0.3 (Lower volatility than the market)
*   **Cap:** $11.5 Billion (Market Capitalization)

**Analysis of Return Rate and Alpha/Beta:**

*   TEM has significantly underperformed the S&P 500. Its cumulative return is half that of VOO, resulting in a -15% divergence.
*   The large negative Alpha (-14.0%) confirms this underperformance.
*   The high Maximum Drawdown (76.7%) indicates significant risk and volatility.
*   The Beta of 0.3 suggests that TEM is less volatile than the overall market. However, the high MDD contradicts this somewhat, implying large price swings are still possible, independent of market movement.

**2) Recent Stock Price Fluctuations:**

*   **Current Close:** $64.46
*   **Previous Close:** $62.21
*   **Change:** +3.62%
*   **5-day SMA:** $65.61
*   **20-day SMA:** $72.86
*   **60-day SMA:** $80.13

**Analysis of Fluctuations:**

*   The stock has shown a positive price movement today.
*   The stock price is below all moving averages. The 5-day SMA < 20-day SMA < 60-day SMA sequence suggests a downtrend.

**3) RSI, PPO, Market Risk, and Expected Return:**

*   **MRI (Market Risk Indicator):** 0.7 (Medium Investment)
*   **RSI (Relative Strength Index):** 23.89 (Oversold)
*   **PPO (Percentage Price Oscillator):** -1.42
*   **Hybrid Signal:** Buy 100% of cash (14 shares - Very Safe - MRI:0.90), invest 5% monthly.
*   **Recent Divergence Change (20 days):** -9.7 (Negative, indicating a short-term decline in relative performance)
*   **Expected Return:** NaN (Not Available)

**Analysis of Indicators:**

*   The RSI indicates the stock is oversold, which could suggest a potential buying opportunity.
*   The negative PPO also points to a downtrend.
*   The MRI suggests a medium level of investment risk.
*   The hybrid signal suggests a "very safe" buy recommendation (likely based on the low RSI and oversold conditions), with a small monthly investment.
*   The recent negative divergence change confirms recent underperformance relative to the comparison.
*   The "NaN" Expected Return is a significant issue. An investor needs to know what the potential upside is to make an informed decision.

**4) Recent News & Significant Events:**

*   **[2025-12-20]** TEM stock fell 9% this week.
*   **[2025-12-10]** Is TEM a Buy, Hold, or Sell During Its Pivotal Transition?
*   **[2025-12-20]** Tempus AI Logs First Non-GAAP Profit And Bullish 2025 Outlook Is The Thesis Evolving?
*   **[2025-12-18]** Tempus AI (NASDAQ:TEM) EVP Erik Phelps Sells 1,302 Shares
*   **[2025-12-16]** Tempus AI: Plenty Of Growth Catalysts Ahead, Grab It While Itâ€™s Down (TEM)
*   **[2025-12-19]** Tempus AI Approaching Profitability Despite GAAP Losses

**Analysis of News:**

*   The news is mixed. Some articles highlight growth catalysts and a path to profitability, while others note the stock's recent decline and executive selling shares.
*   The mention of a "pivotal transition" suggests potential uncertainty and risk.
*   The fact that the company is logging its first non-GAAP profit is positive, but the emphasis on *non-GAAP* is a potential red flag. Investors should understand what adjustments are being made to reach this profit.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy
*   **Mean Rating:** 2.14 (Buy)
*   **Number of Opinions:** 12
*   **Target Price (avg/high/low):** 90.17 / 105.00 / 80.00
*   **Recent Rating Changes:** Not available

**Analysis of Analyst Opinions:**

*   Analysts are generally positive on TEM, with a "Buy" consensus and a target price significantly higher than the current price.
*   However, the lack of recent rating changes makes it difficult to assess the current sentiment.

**5) Comprehensive Analysis:**

Tempus AI (TEM) is a high-risk, potentially high-reward stock. While it operates in a promising sector (precision medicine with AI), the data suggests caution is warranted.

**Key Concerns:**

*   **Significant Underperformance:** TEM has significantly underperformed the S&P 500.
*   **High Volatility:** The large Maximum Drawdown (MDD) indicates a history of large price swings.
*   **Negative Alpha:** Confirmed underperformance.
*   **Mixed News:** While some news is positive, there are also reports of stock declines, executive selling, and a "pivotal transition" that could introduce uncertainty. The reliance on non-GAAP profit needs to be examined.

**Potential Upsides:**

*   **Oversold Conditions:** The RSI suggests the stock is oversold, and a bounce is possible.
*   **Analyst Buy Rating:** Analysts generally have a positive outlook on the stock.
*   **Growth Catalysts:** Some news suggests the company has growth catalysts ahead.

**Overall Recommendation:**

Given the significant risks and underperformance, a **cautious approach** is advisable. While the oversold conditions and analyst optimism might tempt some investors, the high volatility, negative alpha, and mixed news require thorough due diligence.

**Before investing, it is essential to:**

*   **Understand the Non-GAAP Profit:** Analyze how the company achieves profitability using non-GAAP measures.
*   **Assess the "Pivotal Transition":** Understand the nature of the transition and its potential impact on the company.
*   **Evaluate the Risks:** Consider the high volatility and potential for further underperformance.
*   **Determine a Realistic Target Price:** Consider the analyst target prices in light of the company's performance and risks.

The high MDD and negative alpha suggest that TEM is not suitable for risk-averse investors. Only investors with a high-risk tolerance and a thorough understanding of the company's fundamentals should consider investing in TEM.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.